Harvard Women's Health Watch

In the journals: Study shows that a new type of osteoporosis drug reduces fracture risk

Testing of a new type of drug for the treatment of osteoporosis found that it reduced fracture risk, though it has not yet been compared to the other osteoporosis medications already available.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In